Breaking News Instant updates and real-time market news.

BEAT

BioTelemetry

$50.97

1.1 (2.21%)

16:20
10/30/18
10/30
16:20
10/30/18
16:20

BioTelemetry raises FY18 revenue view to $397M-$400M, consensus $394.21M

Raising full-year revenue guidance to $397M to $400M with an approximate 28% adjusted EBITDA margin.

  • 30

    Oct

BEAT BioTelemetry
$50.97

1.1 (2.21%)

09/14/18
LSCM
09/14/18
NO CHANGE
Target $90
LSCM
Buy
Apple Watch more likely a positive for BioTelemetry, says Lake Street
After spending time with Joe Capper and Heather Getz, CEO and CFO of BioTelemetry (BEAT), Lake Street analyst Brooks O'Neil senses that Apple's (AAPL) Watch Series 4, which includes a built-in electrocardiogram, is more likely a positive for BioTelemetry "than a buzzer sounding a flat-line for the company's future." BioTelemetry remains the leading cardiac monitoring company and this is likely to continue for the foreseeable future, O'Neil tells investors in a research note. He points out the company has a partnership with Apple in cardiac monitoring and with Sanofi (SNY) and Alphabet (GOOG) in diabetes. The analyst's guesses that its partnership is one element giving BioTelemetry management comfort in evaluating the role Apple might play in the company's future. O'Neil reaffirms a Buy rating on the shares with a $90 price target.
09/14/18
RAJA
09/14/18
NO CHANGE
Target $66
RAJA
Outperform
BioTelemetry price target raised to $66 from $57 at Raymond James
Raymond James analyst Jayson Bedford raised Outperform rated Bio Telemetry's price target to $66 from $57 saying the seamless integration of the Lifewatch acquisition combined with new product introductions has increased growth and driven improved visibility.
08/31/18
RHCO
08/31/18
NO CHANGE
Target $67
RHCO
Buy
BioTelemetry price target raised to $67 from $52 at SunTrust
SunTrust analyst Bruce Nudell raised his price target on BioTelemetry to $67 and kept his Buy rating to reflect his updated FY18 revenue model of $394.7M vs. $385.6M prior view. The analyst also raised his FY18 EPS view to $1.50 from $1.34 as part of his new assumption of a 9% top-line growth over the next 3 years, saying the mobile cardiac outpatient telemetry market where the company has a 70% market share is growing by over 9%. Nudell further notes BioTelemetry opportunity in the Extended Holter business where the company remains a "minority player".
07/26/18
LSCM
07/26/18
NO CHANGE
Target $90
LSCM
Buy
BioTelemetry price target raised to $90 from $50 at Lake Street
After BioTelemetry reported better than expected Q2 sales and earnings, Lake Street analyst Brooks O'Neil said he continues to think LifeWatch integration is ahead of schedule and the company's Research Services segment has "tremendous momentum." The analyst, who views BioTelemetry as "the leading remote patient monitoring company," believes the stock deserves to reflect that leadership position. He raised his target on BioTelemetry to $90 and keeps a Buy rating on the stock, which is up 8% to $52.60 in pre-market trading.

TODAY'S FREE FLY STORIES

EMN

Eastman Chemical

$83.11

0.34 (0.41%)

09:22
11/19/18
11/19
09:22
11/19/18
09:22
Recommendations
Eastman Chemical analyst commentary  »

Eastman Chemical price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YETI

Yeti

$16.99

0.1 (0.59%)

09:21
11/19/18
11/19
09:21
11/19/18
09:21
Initiation
Yeti initiated  »

William Blair starts Yeti…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

09:20
11/19/18
11/19
09:20
11/19/18
09:20
General news
U.S. NAHB housing market index preview: »

U.S. NAHB housing market…

ADS

Alliance Data

$198.00

0.38 (0.19%)

09:18
11/19/18
11/19
09:18
11/19/18
09:18
Recommendations
Alliance Data analyst commentary  »

Alliance Data price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CORT

Corcept Therapeutics

$13.02

0.005 (0.04%)

09:18
11/19/18
11/19
09:18
11/19/18
09:18
Hot Stocks
Corcept Therapeutics doses first patient in Phase 3 trial of relacorilant »

Corcept Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
11/19/18
11/19
09:18
11/19/18
09:18
Options
Overnight activity included 313 trades in SPX and 10 trades in VIX »

313 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLTZY

Tele2

$0.00

(0.00%)

09:17
11/19/18
11/19
09:17
11/19/18
09:17
Upgrade
Tele2 rating change  »

Tele2 upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKER

Akers Biosciences

$1.23

-0.365 (-22.88%)

09:16
11/19/18
11/19
09:16
11/19/18
09:16
Hot Stocks
Akers Biosciences considering business combinations in cannabis related industry »

Akers Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APDN

Applied DNA Sciences

$1.08

-0.015 (-1.37%)

09:15
11/19/18
11/19
09:15
11/19/18
09:15
Hot Stocks
Applied DNA Sciences, Eurofins sign collaboration agreement »

Applied DNA Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REN

Resolute Energy

$30.51

0.67 (2.25%)

, VKTX

Viking Therapeutics

$11.65

0.27 (2.37%)

09:14
11/19/18
11/19
09:14
11/19/18
09:14
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Resolute Energy…

REN

Resolute Energy

$30.51

0.67 (2.25%)

VKTX

Viking Therapeutics

$11.65

0.27 (2.37%)

ZAYO

Zayo Group

$23.70

1.495 (6.73%)

LEJU

Leju

$1.71

0.05 (3.01%)

JD

JD.com

$23.04

-1.18 (-4.87%)

XEC

Cimarex Energy

$88.63

-0.27 (-0.30%)

PCG

PG&E

$24.39

6.62 (37.25%)

MDGL

Madrigal Pharmaceuticals

$129.47

-3.36 (-2.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 03

    Dec

IRT

Independence Realty Trust

$9.99

0.21 (2.15%)

09:14
11/19/18
11/19
09:14
11/19/18
09:14
Initiation
Independence Realty Trust initiated  »

Independence Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACC

American Campus

09:14
11/19/18
11/19
09:14
11/19/18
09:14
Initiation
American Campus initiated  »

American Campus initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UDR

UDR, Inc.

$41.06

0.6 (1.48%)

09:14
11/19/18
11/19
09:14
11/19/18
09:14
Initiation
UDR, Inc. initiated  »

UDR, Inc. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMRN

Immuron

$8.50

(0.00%)

, SGYP

Synergy Pharmaceuticals

$0.39

0.0211 (5.73%)

09:13
11/19/18
11/19
09:13
11/19/18
09:13
Hot Stocks
Immuron appoints Gary Jacob CEO »

Immuron (IMRN) announced…

IMRN

Immuron

$8.50

(0.00%)

SGYP

Synergy Pharmaceuticals

$0.39

0.0211 (5.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

INTC

Intel

$48.85

0.73 (1.52%)

09:12
11/19/18
11/19
09:12
11/19/18
09:12
Recommendations
Intel analyst commentary  »

Intel to benefit from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 04

    Dec

OTEX

OpenText

$33.20

0.32 (0.97%)

09:10
11/19/18
11/19
09:10
11/19/18
09:10
Hot Stocks
Sun Chemical selects OpenText to improve customer service »

OpenText announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BFIN

BankFinancial

$14.55

0.17 (1.18%)

09:09
11/19/18
11/19
09:09
11/19/18
09:09
Hot Stocks
BankFinancial extends, expands share repurchase program »

BankFinancial announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMHC

Houghton Mifflin

$8.84

-0.12 (-1.34%)

09:09
11/19/18
11/19
09:09
11/19/18
09:09
Hot Stocks
Houghton Mifflin: Texas SBE approves new K-8 reading programs »

Houghton Mifflin Harcourt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEJU

Leju

$1.71

0.05 (3.01%)

09:06
11/19/18
11/19
09:06
11/19/18
09:06
Earnings
Breaking Earnings news story on Leju »

Leju sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

LEJU

Leju

$1.71

0.05 (3.01%)

09:06
11/19/18
11/19
09:06
11/19/18
09:06
Earnings
Leju reports Q3 adj. EPS 8c, one estimate (2c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

GLYC

GlycoMimetics

$11.94

0.34 (2.93%)

09:05
11/19/18
11/19
09:05
11/19/18
09:05
Hot Stocks
GlycoMimetics enrolls first patient in Phase 3 clinical trial of uproleselan »

GlycoMimetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBA

Walgreens Boots Alliance

$82.54

0.25 (0.30%)

, CVS

CVS Health

$79.33

-0.48 (-0.60%)

09:05
11/19/18
11/19
09:05
11/19/18
09:05
Hot Stocks
Florida AG amends opioid lawsuit complaint to include Walgreens, CVS »

Attorney General Pam…

WBA

Walgreens Boots Alliance

$82.54

0.25 (0.30%)

CVS

CVS Health

$79.33

-0.48 (-0.60%)

INSY

Insys Therapeutics

$7.08

-0.13 (-1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

DISH

Dish

$32.85

-0.25 (-0.76%)

, CTL

CenturyLink

$19.16

0.19 (1.00%)

09:02
11/19/18
11/19
09:02
11/19/18
09:02
Hot Stocks
Dish names Atilla Tinic as Chief Information Officer »

DISH (DISH) announced…

DISH

Dish

$32.85

-0.25 (-0.76%)

CTL

CenturyLink

$19.16

0.19 (1.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

AVNW

Aviat Networks

$14.92

-0.43 (-2.80%)

, MSI

Motorola Solutions

$129.97

0.72 (0.56%)

09:01
11/19/18
11/19
09:01
11/19/18
09:01
Hot Stocks
Aviat Networks selected by Motorola Solutions for Florida's P25 network »

Aviat Networks (AVNW)…

AVNW

Aviat Networks

$14.92

-0.43 (-2.80%)

MSI

Motorola Solutions

$129.97

0.72 (0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 04

    Dec

  • 18

    Dec

  • 19

    Dec

YETI

Yeti

$16.99

0.1 (0.59%)

09:00
11/19/18
11/19
09:00
11/19/18
09:00
Initiation
Yeti initiated  »

Yeti initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.